Back to News Hub
🇪🇺Tech.eu
July 15, 2026
Funding & Investment

Neko Health raises $700M as demand grows for preventive health scans

Overview

Neko Health today announced the completion of its $700 million Series C funding round. The round was led by Lightspeed Venture Partners and co-led by O. Venture Partners, with participation from e...

Key Takeaways

  • Fresh funding will support US expansion, new clinics, and continued development of Neko's proprietary hardware and health data platform.

    Healthtech Neko Health raises $700M as demand grows for preventive health scans Fresh funding will support US expansion, new clinics, and continued development of Neko's proprietary hardware and health data platform.

  • Founded by Spotify's Daniel Ek and Hjalmar Nilsonne, Neko Health is a health technology company redefining how people understand and act on their health.

    At the heart of Neko's offering is the Neko Health Scan, a 60-minute, comprehensive, non-invasive, and radiation-free health assessment that captures millions of health data points, priced at £299 in the UK and 2,750 SEK in Sweden.

  • The addition of body composition measures, captured in seconds during the scan, and clinician review of wearable data, is now live across all clinics - giving members an even more detailed picture of their health both in the moment and between visits.

    This is the latest step in a program of continuous innovation, made possible by Neko's ownership of every part of its tech stack in-house.

  • The clearest proof is in our members: the vast majority of our members return after their first scan, and when they do, their health markers move in the right direction.
  • I've invested in Neko because they offer beautiful simplicity, and only simplicity scales: you get a high-definition map of your biology in less than 60 minutes, explained by an unhurried doctor, all in one location and for £299.

Stats & Key Facts

  • #Neko Health today announced the completion of its $700 million Series C funding round.
  • #Healthtech Neko Health raises $700M as demand grows for preventive health scans Fresh funding will support US expansion, new clinics, and continued development of Neko's proprietary hardware and health data platform.
  • #Cate Lawrence 2 hours ago Share Share Send email Copy link Neko Health today announced the completion of its $700 million Series C funding round.
  • #The fundraise follows a $260 million Series B in January 2025.

Fresh funding will support US expansion, new clinics, and continued development of Neko's proprietary hardware and health data platform. Healthtech Neko Health raises $700M as demand grows for preventive health scans Fresh funding will support US expansion, new clinics, and continued development of Neko's proprietary hardware and health data platform. Cate Lawrence 2 hours ago Share Share Send email Copy link Neko Health today announced the completion of its $700 million Series C funding round.

The round was led by Lightspeed Venture Partners and co-led by O. Venture Partners, with participation from existing investors Atomico, General Catalyst, and Lakestar, alongside new backers including Liberty City Ventures, Positive Sum, and BDT & MSD. The fundraise follows a $260 million Series B in January 2025.

Founded by Spotify's Daniel Ek and Hjalmar Nilsonne, Neko Health is a health technology company redefining how people understand and act on their health. At the heart of Neko's offering is the Neko Health Scan, a 60-minute, comprehensive, non-invasive, and radiation-free health assessment that captures millions of health data points, priced at £299 in the UK and 2,750 SEK in Sweden. Using proprietary sensors alongside blood analysis, the scan assesses skin health, including moles and marks, biomarkers to identify pre-diabetes risk, as well as blood abnormalities and risk factors linked to metabolic syndrome, stroke, and heart attack.

For more details please read the original article at Tech.eu.

Continue Learning

Originally published by Tech.eu
Read the original

Comments

Sign in to join the conversation